Picture of Kaleido Biosciences logo

KLDO — Kaleido Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Kaleido Biosciences Announces Expansion Of Collaboration With Janssen To Explore Potential Of Microbiome Metabolic Therapies (Mmt) To Prevent Childhood-Onset Of Atopic, Immune And Metabolic Conditions

Dec 6 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES ANNOUNCES EXPANSION OF COLLABORATION
WITH
JANSSEN TO EXPLORE POTENTIAL OF MICROBIOME METABOLIC THERAPIES
(MMT™) TO PREVENT CHILDHOOD-ONSET OF ATOPIC, IMMUNE AND
METABOLIC CONDITIONS
    * KALEIDO BIOSCIENCES INC - EXISTING AGREEMENT WITH JANSSEN
HAS
BEEN EXTENDED
    * KALEIDO BIOSCIENCES INC - JANSSEN WILL FUND ADDITIONAL
COSTS
ASSOCIATED WITH EXPANDED SCOPE OF COLLABORATION

Source text for Eikon:  ID:nGNX2QTmdk 
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kaleido Biosciences

See all news